Christie Ballantyne, MD, explains how the CORALreef Extension study adds safety exposure and shows LDL-C lowering with oral enlicitide is sustained over time.
|Videos|March 23, 2018
The Expanding Role of Pharmacy Technicians
In Idaho, pharmacists are able to delegate tasks, such as final product verification, transferring prescriptions, and even administering vaccines, to pharmacy technicians.
Advertisement
In this clip, Alex J. Adams, PharmD, MPH, from the Idaho State Board of Pharmacy, discusses why expanding the role of pharmacy technicians improves workflow efficiencies and benefits the pharmacy team as a whole. In Idaho, pharmacists are able to delegate tasks, such as final product verification, transferring prescriptions, and even administering vaccines, to pharmacy technicians.
Advertisement
Related to this article
The glucagon/GLP-1 dual agonist did not raise major adverse cardiovascular event risk in adults with obesity, but GI-related discontinuations were high.
Post hoc AHA 2026 data show the oral GLP-1 receptor agonist lowered systolic blood pressure across hypertension stages, partly beyond weight loss.
Early metformin may curb insulin starts in gestational diabetes, while a separate analysis ties a history of the condition to advanced CKM syndrome.
Pharmacy Times previews enlicitide, survodutide, diet and heart failure risk, and pharmacist-led HF care ahead of the AHA Scientific Sessions in Chicago.
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
Garlic has a long history in traditional medicine, but evidence for its benefits varies by preparation, and patients taking medications that increase bleeding risk should use it with caution.
About 89% of Americans live within 5 miles of a pharmacy, but proximity says little about whether they can afford their medications or get real counseling.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Oral PCSK9 Inhibitor Enlicitide Sustains LDL-C Reductions
2
FDA Requires Class-Wide GLP-1 RA Labeling Changes for Potential NAION Risk
3
FDA Approves Pimicotinib for Tenosynovial Giant Cell Tumor
4
The Most Accessible Healthcare Professional—But Accessible to Whom?
5